{{Rsnum
|rsid=6103
|Gene=SERPINB2
|Chromosome=18
|position=63903269
|Orientation=plus
|GMAF=0.3301
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;G)
|geno3=(G;G)
|Gene_s=SERPINB2
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;G)
| geno3=(G;G)
| CEU | 59.3 | 33.6 | 7.1
| HCB | 25.5 | 48.9 | 25.5
| JPT | 41.6 | 46.0 | 12.4
| YRI | 34.2 | 45.9 | 19.9
| ASW | 47.4 | 45.6 | 7.0
| CHB | 25.5 | 48.9 | 25.5
| CHD | 34.0 | 44.3 | 21.7
| GIH | 53.0 | 36.0 | 11.0
| LWK | 50.9 | 39.1 | 10.0
| MEX | 38.6 | 45.6 | 15.8
| MKK | 59.0 | 33.3 | 7.7
| TSI | 56.4 | 37.6 | 5.9
| HapMapRevision=28
}}{{PMID Auto
|PMID=21245421
|Title=Genetic Factors Underlying the Risk of Thalidomide-Related Neuropathy in Patients With Multiple Myeloma
}}

{{GET Evidence
|gene=SERPINB2
|aa_change=Asn404Lys
|aa_change_short=N404K
|impact=not reviewed
|qualified_impact=Insufficiently evaluated not reviewed
|inheritance=unknown
|quality_scores=Array
|dbsnp_id=rs6103
|overall_frequency_n=2916
|overall_frequency_d=10758
|overall_frequency=0.271054
|n_genomes=26
|n_genomes_annotated=0
|n_haplomes=31
|n_articles=0
|n_articles_annotated=0
|nblosum100=1
|autoscore=0
|webscore=N
}}
{{on chip | Affy GenomeWide 6}}
{{on chip | HumanOmni1Quad}}